정량 흡입기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global Metered Dose Inhalers Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Metered Dose Inhalers Market Size (2025E): USD 30.3 Bn
• Projected Market Value (2032F): USD 41 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Metered Dose Inhalers Market - Report Scope:

The Metered Dose Inhalers (MDI) Market comprises inhalation devices that deliver precise doses of medication for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These inhalers are widely used due to their portability, ease of use, and effectiveness in delivering medication directly to the lungs. The market is driven by the increasing prevalence of respiratory diseases, advancements in inhaler technology, and growing awareness of inhalation therapy benefits.

Market Growth Drivers:

Several key factors are driving the growth of the global Metered Dose Inhalers Market, including rising cases of asthma, COPD, and other respiratory conditions due to pollution, smoking, and lifestyle changes. Technological advancements in inhaler design, such as breath-actuated MDIs and smart inhalers with digital monitoring, are enhancing patient compliance and treatment outcomes. Additionally, the growing geriatric population and increased healthcare expenditure are fueling demand for MDIs. Expanding healthcare infrastructure in emerging economies further contributes to market growth.

Market Restraints:

Despite strong growth prospects, the Metered Dose Inhalers Market faces challenges such as the high cost of inhaler devices, regulatory hurdles, and concerns over the environmental impact of propellants used in MDIs. Limited patient awareness about correct inhaler techniques can also impact treatment efficacy. The market may experience challenges related to stringent government regulations regarding inhaler formulations and the need for sustainable alternatives to traditional hydrofluoroalkane (HFA) propellants.

Market Opportunities:

The Metered Dose Inhalers Market presents substantial growth opportunities, including the development of eco-friendly inhalers to replace traditional propellants and the integration of smart technology for enhanced medication tracking. Increasing investments in healthcare infrastructure in emerging economies and the rising adoption of homecare solutions provide further market expansion opportunities. Additionally, strategic collaborations between pharmaceutical companies and healthcare providers can drive innovation and improve patient access to advanced inhalation therapies.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the Metered Dose Inhalers Market?
• Which regions and market segments are witnessing the highest demand for metered dose inhalers?
• How are technological advancements influencing the competitive landscape of the Metered Dose Inhalers Market?
• Who are the key players in the Metered Dose Inhalers Market, and what strategies are they employing to sustain market leadership?
• What are the emerging trends and future outlooks for the Metered Dose Inhalers Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Metered Dose Inhalers Market, such as Cipla Inc., Presspart Manufacturing Ltd., and GlaxoSmithKline Pharmaceuticals Ltd., are focusing on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies are investing in the development of next-generation inhalers, including breath-actuated and digitally connected devices, to improve patient compliance and treatment efficiency. Collaborations with healthcare providers, digital health platforms, and regulatory agencies are key strategies to expand market reach and enhance patient outcomes. Sustainability initiatives, such as developing low-carbon-footprint propellants, are also gaining importance in the market.

Key Companies Profiled:

• Cipla Inc.
• Presspart Manufacturing Ltd.
• Midascare Pharmaceuticals Pvt. Ltd.
• Beximco Pharma Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• 3M Pharmaceuticals Pty Ltd.
• Biocare Manufacturing Sdn Bhd.
• Anomatic Innovation & Design Center & Manufacturing
• Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation:

By Type:

• Reliever Inhaler
• Long-acting Bronchodilators Inhaler

By End User:

• Homecare
• Hospitals
• Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa
• Latin America

Table of Contents

1. Global Metered Dose Inhalers Market Outlook

2. Global Metered Dose Inhalers Market Outlook: Services

• 2.1. Introduction/Key Findings
• 2.2. Historical Market Size (US$ Bn ) and Analysis, By Services, 2019-2024
• 2.3. Current Market Size (US$ Bn ) and Analysis and Forecast, By Services, 2025-2032
• 2.4. Future Market Projections
• 2.5. Premium Market Insights
• 2.6. Industry Developments and Key Market Events
• 2.7. PMR Analysis and Recommendations

3. Market Overview

• 3.1. Market Scope and Definition
• 3.2. Market Dynamics
  • 3.2.1. Drivers
  • 3.2.2. Restraints
  • 3.2.3. Opportunity
  • 3.2.4. Challenges
  • 3.2.5. Key Trends
• 3.3. Macro-Economic Factors
  • 3.3.1. Global Sectorial Outlook
  • 3.3.2. Global GDP Growth Outlook
• 3.4. COVID-19 Impact Analysis
• 3.5. Forecast Factors - Relevance and Impact

4. Value Added Insights

• 4.1. Regulatory Landscape
• 4.2. Product Adoption Analysis
• 4.3. Value Chain Analysis
• 4.4. Key Deals and Mergers
• 4.5. PESTLE Analysis
• 4.6. Porter's Five Force Analysis

5. Global Metered Dose Inhalers Market Outlook:

• 5.1. Key Highlights
  • 5.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
  • 5.1.2. Absolute $ Opportunity
• 5.2. Market Size (US$ Bn ) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
  • 5.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
• 5.3. Global Metered Dose Inhalers Market Outlook: Type
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Bn ) Analysis, By Type, 2019-2024
  • 5.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 5.3.3.1. Reliever Inhaler
    • 5.3.3.2. Long-acting bronchodilators Inhaler
  • 5.3.4. Market Attractiveness Analysis: Type
• 5.4. Global Metered Dose Inhalers Market Outlook: End User
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Bn ) Analysis, By End User, 2019-2024
  • 5.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 5.4.3.1. Homecare
    • 5.4.3.2. Hospitals
    • 5.4.3.3. Clinics
  • 5.4.4. Market Attractiveness Analysis: End User

6. Global Metered Dose Inhalers Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
• 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Metered Dose Inhalers Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Type
  • 7.2.3. By End User
• 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 7.4.1. Reliever Inhaler
  • 7.4.2. Long-acting bronchodilators Inhaler
• 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 7.5.1. Homecare
  • 7.5.2. Hospitals
  • 7.5.3. Clinics
• 7.6. Market Attractiveness Analysis

8. Europe Metered Dose Inhalers Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Type
  • 8.2.3. By End User
• 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 8.4.1. Reliever Inhaler
  • 8.4.2. Long-acting bronchodilators Inhaler
• 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 8.5.1. Homecare
  • 8.5.2. Hospitals
  • 8.5.3. Clinics
• 8.6. Market Attractiveness Analysis

9. East Asia Metered Dose Inhalers Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Type
  • 9.2.3. By End User
• 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 9.4.1. Reliever Inhaler
  • 9.4.2. Long-acting bronchodilators Inhaler
• 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 9.5.1. Homecare
  • 9.5.2. Hospitals
  • 9.5.3. Clinics
• 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Metered Dose Inhalers Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Type
  • 10.2.3. By End User
• 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 10.4.1. Reliever Inhaler
  • 10.4.2. Long-acting bronchodilators Inhaler
• 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 10.5.1. Homecare
  • 10.5.2. Hospitals
  • 10.5.3. Clinics
• 10.6. Market Attractiveness Analysis

11. Latin America Metered Dose Inhalers Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Type
  • 11.2.3. By End User
• 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 11.4.1. Reliever Inhaler
  • 11.4.2. Long-acting bronchodilators Inhaler
• 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 11.5.1. Homecare
  • 11.5.2. Hospitals
  • 11.5.3. Clinics
• 11.6. Market Attractiveness Analysis

12. Middle East & Africa Metered Dose Inhalers Market Outlook:

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Type
  • 12.2.3. By End User
• 12.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
  • 12.4.1. Reliever Inhaler
  • 12.4.2. Long-acting bronchodilators Inhaler
• 12.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
  • 12.5.1. Homecare
  • 12.5.2. Hospitals
  • 12.5.3. Clinics
• 12.6. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. Market Type
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Cipla Inc.
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Products
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Presspart Manufacturing Ltd.
  • 13.3.3. Midascare Pharmaceuticals Pvt. Ltd.
  • 13.3.4. Beximco Pharma Ltd.
  • 13.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
  • 13.3.6. 3M Pharmaceuticals Pty Ltd.
  • 13.3.7. Biocare Manufacturing Sdn Bhd.
  • 13.3.8. Anomatic Innovation & Design Center & Manufacturing
  • 13.3.9. Aristo Pharma Ltd.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations